Evidence map›Paper›PMID 42324706›Full record

ArticleAmerican journal of hematology2026

When Cure Meets Susceptibility: APOL1 -Associated Kidney Injury After Gene Therapy for Sickle Cell Disease.

Evelyn Gartstein, Lauren McNaughton, O N Ray Bignall, Shamlal Mangray, Anthony Villella, Susan Creary, Rolla Abu-Arja, Sonali Chaudhury, Hemalatha G Rangarajan

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Evelyn GartsteinDepartment of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio, USA.
Lauren McNaughtonDivision of Nephrology and Hypertension, Nationwide Children's Hospital, Columbus, Ohio, USA.
O N Ray BignallDivision of Nephrology and Hypertension, Nationwide Children's Hospital, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0003-0798-448X
Shamlal MangrayDepartment of Pathology, Nationwide Children's Hospital, Columbus, Ohio, USA.
Anthony VillellaDepartment of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Susan CrearyDepartment of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0002-4730-8139
Rolla Abu-ArjaDepartment of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0001-9768-7520
Sonali ChaudhuryDivision of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Lurie Children's Hospital, Chicago, Illinois, USA.
Hemalatha G RangarajanDepartment of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

APO1 mutationschemotherapygene therapyrenal diseasesickle cell disease

Identifiers

PMID42324706
PMCPMC13428369

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.